mikafungiin
Mikafungiin, more commonly spelled micafungin, is an antifungal medication in the echinocandin class. It is used to treat certain invasive fungal infections caused by Candida species and to prevent Candida infections in specific high-risk patients. Micafungin is administered by intravenous infusion and has no oral form.
Mechanism of action and spectrum: micafungin inhibits the enzyme beta-1,3-D-glucan synthase, which is essential for synthesizing
Clinical uses: indications commonly include treatment of candidemia and other forms of invasive candidiasis, and treatment
Administration and pharmacokinetics: micafungin is given once daily by IV infusion. Dosing depends on the indication
Safety and resistance: common adverse effects include fever, rash, nausea, and liver enzyme elevations. Hypersensitivity reactions
History and naming: micafungin was developed by Fujisawa Pharmaceutical and later marketed under the brand name